Akoya Biosciences, Inc. AKYA
Set alert
1.29 0.00 0.00%
At close · Jul 8
1.29 Day range 1.29
1.88 52-week range 6.31
- Open
- 1.29
- Prev close
- 1.29
- Mkt cap
- 119.45M
- Vol
- 715.25K
- Avg vol
- 233.37K
- EPS
- -1.16
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.29
- High
- 1.29
- Forward P/E
- -4.38
- Beta
- 1.35
- Short ratio
- 13.43
- Inst. own
- 70.19%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 5, 2024
- 50-d avg
- 2.63
- 200-d avg
- 2.91
- 1y target
- 3.50
Financial health
Altman Z-Score
-4.24 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -2.0×
FY 2019 5y median -5.1× FY 2024
P/S 1.4×
FY 2019 5y median 4.8× FY 2024
P/B 14.9×
FY 2019 5y median 6.2× FY 2024
P/FCF -2.4×
FY 2019 5y median -5.9× FY 2024
EV/EBITDA -5.0×
FY 2019 5y median -6.2× FY 2024
EV/Sales 2.3×
FY 2019 5y median 4.8× FY 2024
FCF Yield -41.1%
FY 2019 5y median -16.8% FY 2024
Profitability
Gross Margin 58.6%
FY 2019 5y median 58.6% FY 2024
Operating Margin -57.2%
FY 2019 5y median -59.7% FY 2024
Net Margin -67.8%
FY 2019 5y median -67.8% FY 2024
ROE -729.0%
FY 2019 5y median -117.8% FY 2024
ROIC -47.3%
FY 2019 5y median -38.8% FY 2024
ROA -44.3%
FY 2019 5y median -35.1% FY 2024
Growth (YoY)
Revenue -15.5%
FY 2019 FY 2024
Operating Income 19.0%
FY 2019 FY 2024
EPS (diluted) 21.7%
FY 2019 FY 2024
Free Cash Flow 14.7%
FY 2019 FY 2024
Financial Health
Current Ratio 2.6×
FY 2019 5y median 3.0× FY 2024
Quick Ratio 1.8×
FY 2019 5y median 2.6× FY 2024
Debt / Equity 11.1×
FY 2019 5y median 1.6× FY 2024
Net Debt / EBITDA -1.9×
FY 2019 5y median -0.1× FY 2024
Interest Coverage -4.5×
FY 2019 5y median -6.6× FY 2024
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31